Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial

BACKGROUND: In the GLOBAL LEADERS trial, ticagrelor monotherapy beyond 1 month compared with standard antiplatelet regimens after coronary stent implantation did not improve outcomes at intention‐to‐treat analysis. Considerable differences in treatment adherence between the experimental and control...

Descripción completa

Detalles Bibliográficos
Autores principales: Gragnano, Felice, Zwahlen, Marcel, Vranckx, Pascal, Heg, Dik, Schmidlin, Kurt, Hamm, Christian, Steg, Philippe Gabriel, Gargiulo, Giuseppe, McFadden, Eugene P., Onuma, Yoshinobu, Chichareon, Ply, Benit, Edouard, Möllmann, Helge, Janssens, Luc, Leonardi, Sergio, Zurakowski, Aleksander, Arrivi, Alessio, Van Geuns, Robert Jan, Huber, Kurt, Slagboom, Ton, Calabrò, Paolo, Serruys, Patrick W., Jüni, Peter, Valgimigli, Marco, Windecker, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238541/
https://www.ncbi.nlm.nih.gov/pubmed/35229616
http://dx.doi.org/10.1161/JAHA.121.024291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238541/
https://www.ncbi.nlm.nih.gov/pubmed/35229616
http://dx.doi.org/10.1161/JAHA.121.024291

Ejemplares similares